D8 Holdings Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $345.00M |
|---|---|
| IPO Date | Jul 15, 2020 |
| CEO | David Chu |
| Left Lead | UBS |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Consumer |
| IPO Geography | Global |
| Target Company | Vicarious Surgical |
| Deal Announced | Apr 15, 2021 |
| Deal Size, $M | $1,119.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Sep 15, 2021 |
| Amendment Vote | TBD |
| Closing Date | Sep 17, 2021 |
Formerly DEH
RBOT
RBOT/W
| Price | $0.27 |
|---|---|
| Last closing price | $0.28 |
| H/L, today | $0.26 / $0.30 |
| H/L, 52-week | $0.32 / $3.99 |
| Volume, today | 364,991 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | $0.09 |
|---|---|
| Last closing price | $0.09 |
| High/low price, today | $0.09 / $0.09 |
| Volume, today | 2,495 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on D8 Holdings Corp.:
- Structure and cap table
- 8 directors & officers
- 21 filings and events
- 1 underwriters
- 8 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| David Chu | 65 | Chief Executive Officer and Director |
| Donald Tang | 37 | President and Director |
| Robert Kirby | 51 | Chief Financial Officer |
| Fred Langhammer | 76 | Director |
| Terry Lundgren | 68 | Director |
| Michael Kives | 39 | Director |
| Bryan Baum | Advisor | |
| James Lee | Advisor |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| UBS | BR | 30,000,000 | units |
| 30,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 21 filings.